Tag Health & medicine
Professor honored by American Academy of Microbiology
David Andes researches antibiotic resistance, aiming to understand how pathogens resist treatment and how to overcome their defenses.
Engineer aims to grow spinal tissue in lab
One of regenerative medicine's applications "is the ability to create human tissues and watch diseases occur in a dish, which is extremely powerful for developing new therapies,” says Randolph Ashton, a professor of biomedical engineering.
Surgeon honored for work in orthopedics, sports medicine
The American Medical Women’s Association will honor Dr. Tamara Scerpella with its Woman in Science Award, recognizing her contributions to medical science, through basic research, publications and leadership in the field.
App offers fast track for inserting photos into medical record
Two UW radiologists founded ImageMoverMD, a Middleton business that streamlines image processing in hospitals and clinics, and enables quick consultations between specialists.
UW sleep research high-resolution images show how the brain resets during sleep
Drs. Cirelli, foreground, and Tononi, right, study an image of a mouse brain taken by a scanning electron microscope, left. Thousands of these images…
UW scientists find key cues to regulate bone-building cells
The prospect of regenerating bone lost to cancer or trauma is a step closer to the clinic.
Startup harnesses stem cells for new medical uses
Stem Pharm’s custom materials support growing human cells to evaluate potential drugs or serve as replacement tissues for regenerative medicine.
Awake despite anesthesia? Study finds risk lower than thought
A new study found that, contrary to many previous studies, just more than 4 percent of surgical patients were conscious while under general anesthesia. None remembered it afterward.
New, more effective strategy for producing flu vaccines
A team of researchers led by Yoshihiro Kawaoka has developed technology that could improve the production of vaccines that protect people from influenza B.
Designer switches of cell fate could streamline stem cell biology
The ability to convert cells from one type to another holds great promise, and the new Wisconsin study could help speed research and bring the technology to the clinic faster.
OnLume receives SBIR support for image-guided surgery innovation
The novel technology was developed in collaboration with researchers at the Morgridge Institute for Research and UW–Madison.
Cancer signaling pathway could illuminate new avenue to therapy
The study could establish new avenues of therapeutic treatments for many types of solid tumors.
Morgridge–UW project investigates tissue-engineered arteries for transplant
The prospect of creating artery “banks” could transform treatment of many common heart and vascular ailments. But it’s a big leap from concept to reality.
Students, professor honored for scholarship, community service
Two UW–Madison seniors and a professor have been recognized by the Alliant Energy Foundation and the University of Wisconsin System for their outstanding achievements.
UW-Madison confirms third case of meningococcal disease; free vaccine offered to students
Testing has confirmed meningococcal disease in a third UW–Madison student, who is being treated at a local hospital. Free vaccine clinics for undergraduates continue Monday and Wednesday.
Alumnus’s startup seeks more precise screening for prostate cancer
Success will take years, but if the noninvasive screening test works, it could aid in early detection of a cancer that kills about 26,000 American men every year.
Smart cancer therapies: Teaching the body’s own T-cells to attack tumors
The therapies have already shown tremendous potential in treating blood-based cancers such as leukemia. Now, researchers are investigating ways to make them more versatile and practical.
Study links changes in collagen to worse pancreatic cancer prognosis
The study reinforces growing evidence that collagen, which forms fibrous networks in skin, tendons and muscles, is intimately involved in several cancers.
Madison startup advances three-in-one cancer drug rooted at UW
The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
Meningitis vaccines for students at the SERF continue today
Students 25 and under are urged to stop by the SERF and get the vaccine - it's fast, friendly and free.